According to the Complaint, Immunovant, Inc. is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases. On September 29, 2019, Health Sciences Acquisitions Corporation (“HSAC”), then a blank check company, or SPAC, entered into an agreement with Legacy Immunovant, a private biopharmaceutical company, and shareholders of Legacy Immunovant, to effect a merger between the two entities. As a result of the Merger, HSAC acquired all of the issued and outstanding shares of Legacy Immunovant, and Legacy Immunovant became a wholly owned subsidiary of HSAC. Upon the closing of the Merger, HSAC changed its name to “Immunovant, Inc.”

According to the Complaint, Virtual Multichannel Video Programming Distributors (“vMVPDs”), like Fubo, aggregate live and on-demand television content for delivery over the internet. Unlike traditional cable TV or satellite provider, Fubo does not supply its own data transport infrastructure (e.g., the cable) and instead relies on subscribers to maintain their own internet connection to access its service. vMVPDs offer service and product bundles to subscribers offering channels at a lower monthly rate than offered by traditional cable/satellite providers. There currently are 271 online video services vMVPDs that provide viewers with content from broadcast and cable network as well as streaming providers.

According to the Complaint, EHang Holdings Limited purports to be an autonomous aerial vehicle technology platform company engaged in “pioneering” the future of transportation through the Company’s purportedly proprietarily developed AAVs and related commercial solutions.

According to the Complaint, Jianpu Technology Inc. purports to be the leading independent open platform for discovery and recommendation of financial products in China. The Company touts its proprietary technology which provides search results and recommendations tailored to each user’s financial needs and credit profile.

According to the Complaint, Nantkwest, Inc. is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases.

Plaintiff files this action on behalf of all those individuals and entities who during the period of January 22, 2021 through February 2, 2021, (i) either (a) purchased GameStop shares (b) purchased back an option on GameStop shares, (c) had an option for GameStop shares called away from them, (d) purchased GameStop shares to cover a short position, or (e) had their options expire, and (ii) suffered losses as a result of any transactions identified by clauses (a)-(e) of the Complaint.

According to the Complaint, bluebird bio, Inc. is a biotechnology company that engages in researching, developing, and commercializing transformative gene therapies for severe genetic diseases and cancer. The Company’s gene therapy programs include, among others, LentiGlobin (bb1111) for the treatment of SCD. In May 2020, in the midst of the COVID-19 pandemic, bluebird announced that the Company expected to submit a BLA to the FDA for LentiGlobin for SCD in the second half of 2021.

According to the Complaint, Neos Therapeutics, Inc. is a pharmaceutical company that develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform.

According to the Complaint, GigCapital3, Inc. is a special purpose acquisition company formed for the purpose of effecting a merger, stock exchange, acquisition, reorganization or similar business combination with one or more businesses.

According to the Complaint, Clover Health Investments, Corp. purports to be a Medicare Advantage insurer that uses its software platform, the Clover Assistant, to provide America's seniors with PPO and HMO insurance plans. On January 7, 2021, Clover merged with SPAC Social Capital Hedosophia Holdings Corp. III and began to trade under the symbol CLOV on NASDAQ. On February 4, 2021, Hindenburg Research issued a report stating that prior to the merger, Clover has been under active investigation by the U.S. Department of Justice for issues ranging from kickbacks to marketing practices to undisclosed third-party deals.

According to the Complaint, Tyson Foods, Inc. is purportedly the largest U.S. producer of processed chicken, beef, pork, and protein-based products.

According to the Complaint, S&P Global Inc. provides credit ratings, benchmarks and analytics in the global capital and commodity markets, offering ESG solutions, deep data and insights on critical business factors.

According to the Complaint, iRhythm Technologies, Inc. is a digital healthcare company that seeks to "redefin[e] the way cardiac arrythmias are clinically diagnosed by combining [the Company's] wearable biosensing technology with cloud-based data analytics and deep-learning capabilities." iRhythm offers a portfolio of ambulatory cardiac monitoring services on its platform, called the Zio service.

According to the Complaint, Aerojet Rocketdyne Holdings, Inc. is a world recognized aerospace and defense leader that provides propulsion systems and energetics to the space, missile defense and strategic systems, and tactical systems areas, in support of domestic and international customers.

According to the Complaint, NTN Buzztime, Inc. delivers interactive entertainment and innovative technology that helps its customers acquire, engage and retain patrons.

According to the Complaint, Exxon Mobil Corporation explores for and produces crude oil and natural gas in the U.S. and abroad. One of the Company’s most important oil and gas properties is in the Permian Basin, which is currently the highest-producing oil field in the U.S. In 2017, the Company acquired acreage in the Permian Basin, in an area called the Delaware Basin, for $6.6 billion.

According to the Complaint, Astrazeneca PLC is a multinational biopharmaceutical company and was one of the early front-runners in the race to develop a COVID-19 vaccine. In April 2020, the Company partnered with Oxford University to develop a potential recombinant adenovirus vaccine for the virus, later dubbed AZD1222.

According to the Complaint, Voyager Therapeutics, Inc. is a clinical-stage gene therapy company focused on the development of treatments for patients suffering from severe neurological diseases. Included in the Company’s preclinical programs is VY-HTT01 for Huntington’s Disease.

According to the Complaint, Telenav, Inc. is a leading provider of connected car and location-based services.

According to the Complaint, Anworth Mortgage Asset Corporation is a specialty finance mortgage company organized to qualify as a real estate investment trust (“REIT”).